ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 194 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $11,000 | +22.2% | 245 | +31.7% | 0.00% | – |
| Q2 2020 | $9,000 | -10.0% | 186 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $10,000 | -88.2% | 186 | -86.5% | 0.00% | -66.7% |
| Q4 2019 | $85,000 | +750.0% | 1,380 | +1089.7% | 0.00% | +200.0% |
| Q3 2018 | $10,000 | -52.4% | 116 | -34.8% | 0.00% | 0.0% |
| Q2 2018 | $21,000 | +133.3% | 178 | +21.9% | 0.00% | 0.0% |
| Q4 2017 | $9,000 | -65.4% | 146 | -73.8% | 0.00% | -50.0% |
| Q3 2017 | $26,000 | +4.0% | 558 | -20.7% | 0.00% | 0.0% |
| Q2 2017 | $25,000 | -70.2% | 704 | -74.3% | 0.00% | -75.0% |
| Q1 2017 | $84,000 | -58.2% | 2,735 | -54.4% | 0.01% | -66.7% |
| Q4 2016 | $201,000 | -38.5% | 6,002 | -51.1% | 0.02% | -29.4% |
| Q3 2016 | $327,000 | +118.0% | 12,280 | +79.9% | 0.03% | +61.9% |
| Q2 2016 | $150,000 | +200.0% | 6,825 | +301.5% | 0.02% | +200.0% |
| Q1 2016 | $50,000 | -85.0% | 1,700 | -77.0% | 0.01% | -85.1% |
| Q2 2015 | $333,000 | +674.4% | 7,400 | +428.6% | 0.05% | +683.3% |
| Q1 2015 | $43,000 | -75.8% | 1,400 | -60.0% | 0.01% | -76.9% |
| Q4 2014 | $178,000 | +6.6% | 3,500 | -17.1% | 0.03% | +8.3% |
| Q3 2014 | $167,000 | – | 4,220 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 936,777 | $53,218,000 | 16.69% |
| Fairmount Funds Management LLC | 316,952 | $18,006,000 | 6.55% |
| ARMISTICE CAPITAL, LLC | 1,836,000 | $104,303,000 | 1.77% |
| Soleus Capital Management, L.P. | 182,400 | $10,362,000 | 1.62% |
| Portland Global Advisors LLC | 62,635 | $3,558,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 40,000 | $2,263,000 | 0.55% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $113,336,000 | 0.53% |
| Yorktown Management & Research Co Inc | 10,400 | $591,000 | 0.44% |
| Hennion & Walsh Asset Management, Inc. | 120,240 | $6,831,000 | 0.36% |
| Virtus ETF Advisers LLC | 9,599 | $545,000 | 0.24% |